Low levels of interferon-α induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells

Scandinavian Journal of Immunology

Volumn 50, Issue 5, 1999, Pages 499-509

  Radvanyi, Laszlo G ^a,b   Banerjee, A ^a   Weir, M ^a   Messner, H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL MATURATION; DENDRITIC CELL; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD86; CELL DIFFERENTIATION; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOGLOBULINS; INTERFERON ALFA-2B; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PHENOTYPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032744680     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00625.x     Document Type: Article

References (32)

1. Belardelli F, Gresser I. The neglected role of type I interferon in the T-cell response: Implications for its clinical use. Immunol Today 1996;17:369-72.
2. Saksela E, Virtanen I, Hovi T, Secher DS, Cantell K. Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus infecion. Prog Med Virol 1984;30:78-86.
3. + cell subsets in human peripheral blood. Immunol 1989; 68:486-90.
4. Grage-Griebenow E, Flad HD, Ernst M. Fcγ receptor I (CD64)-negative human monocytes are potent accessory cells in viral antigen-induced T cell activation and exhibit high IFN-α-producing capacity. J Leuk Biol 1996;60:389-96.
5. + blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol 1994;152:4649-62.
6. Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV. Production of interferon alpha/beta by murine dendritic cell lines by virus and bacteria. Scand J Immunol 1997;46:235-41.
7. Wetzler M, Kantarjian H, Kurzrock R, Talpaz M. Interferon-α therapy for chronic myelogenous leukemia. Amer J Med 1995;99: 402-11.
8. Dowding C, Gordon M, Guo AP, et al. Potential mechanisms of action of interferon-α in CML. Leuk Lymph 1993;11:185-91.
9. Jiang YZ, Barrett AJ. Cellular and cytokine-mediated effects of CD4-positive lymphocyte lines generated in vitro against chronic myelogenous leukemia. Exp Hematol 1995;23:1167-72.
10. Lewalle P, Hensel N, Guimaraes A, et al. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: Implications for adoptive immunotherapy with T cells. Br J Haematol 1996;92: 587-94.
11. Gresser I, Maury C, Woodrow D, et al. Interferon treatment markedly inhibits the development of tumour metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia virus. Int J Cancer 1988; 41:135-42.
12. Gresser I, Belardelli F, Tavernier J, et al. Anti-tumour effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor. Int J Cancer 1986;38:771-8.
13. Gresser I, Carnaud C, Maury C, et al. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon α/β treatment in mice. J Exp Med 1991;173:1193-203.
14. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia. J Clin Oncol 1995;13:2401-7.
15. Chakrabarti D, Hultgren B, Stewart TA. IFN-α induces autoimmune T cells through the induction of intracellular adhesion molecule-I and B7.2. J Immunol 1996;157:522-8.
16. Hart D. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-87.
17. Steinman RM, Pack M, Inaba K. Dendritic cell development and maturation. Adv Exp Med Biol 1997;417:1-6.
18. Luft T, Pang KC, Thomas E, et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998;161:1947-53.
19. Romani S, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
20. O'doherty U, Steinman RM, Peng M, et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 1993;178:1067-76.
21. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α. J Exp Med 1994;179:1109-18.
22. Jacobsson B, Bernell P, Arvidsson I, Hast R. Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears. J Histochem Cytochem 1996; 44:1303-9.
23. Tatsumi T, Takehara T, Katayama K, et al. Expression of costimulatory molecules, B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatol 1997;25:1108-14.
24. Chapuis F, Rosenzwajg M, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997;27:431-41.
25. Romani S, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Meth 1997;196:137-51.
26. Jansen JH, Wientjens GJHM, Fibbe WE, Willemze R, Kluin-Nelemans HC. Inhibition of human macrophage colony formation by interleukin-4. J Exp Med 1989;170:577-82.
27. Caux C, Dezutter DC, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
28. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J Immunol Meth 1996; 196:121-35.
29. Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 1997;90:3640-6.
30. Akbar SM, Inaba K, Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-γ: Abrogation of immune response defect to a T-cell-dependent antigen. Immunol 1996;87:519-27.
31. Randolph GW, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998;282:480-3.
32. Paquette RL, Hsu NC, Kiertscher SM, et al. Interferon-alpha and granulocyte-macrophage colony stimulaling factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leuk Biol 1998;64:358-67.